Multi-cancer early detection test in symptomatic patients referred for cancer investigation in England and Wales (SYMPLIFY): a large-scale, observational cohort study - The Lancet Oncology

Triaging suspected cancer with a multi-cancer early detection blood test - The Lancet Oncology

Understanding Liquid Biopsy for Early Cancer Detection and Screening — BLOODPAC

Multi-omics approaches for biomarker discovery in early ovarian cancer diagnosis - eBioMedicine

Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set - Annals of Oncology

Circulating tumor DNA in clinical trials for solid tumors: Challenges and current applications - ScienceDirect

Multi-cancer Early Detection Test In Symptomatic Patients, 40% OFF

Protein biomarkers and alternatively methylated cell-free DNA detect early stage pancreatic cancer

PDF) The presenting symptom signatures of incident cancer: evidence from the English 2018 National Cancer Diagnosis Audit

Cell-free DNA approaches for cancer early detection and interception

Multicancer early detection test: Preclinical, translational, and clinical evidence–generation plan and provocative questions - Kisiel - 2022 - Cancer - Wiley Online Library

Full breakdown of STm model performance. FN, false negative; FP, false

Criteria for Evaluating Multi-cancer Early Detection Tests - touchONCOLOGY

Blood-based tests for multicancer early detection (PATHFINDER): a prospective cohort study - The Lancet